Study of HPN424 in Patients With Advanced Prostate Cancer
Clinical trial NCT03577028 · TERMINATED
Trial details
- NCT number
- NCT03577028
- Sponsor
- Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-24
- Primary completion
- 2023-02-27
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.